Anetta Undas

8.7k total citations · 2 hit papers
282 papers, 6.3k citations indexed

About

Anetta Undas is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Anetta Undas has authored 282 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Cardiology and Cardiovascular Medicine, 102 papers in Pulmonary and Respiratory Medicine and 79 papers in Internal Medicine. Recurrent topics in Anetta Undas's work include Venous Thromboembolism Diagnosis and Management (79 papers), Blood properties and coagulation (73 papers) and Blood Coagulation and Thrombosis Mechanisms (50 papers). Anetta Undas is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (79 papers), Blood properties and coagulation (73 papers) and Blood Coagulation and Thrombosis Mechanisms (50 papers). Anetta Undas collaborates with scholars based in Poland, United States and Germany. Anetta Undas's co-authors include Robert A.S. Ariëns, Kenneth G. Mann, Michał Ząbczyk, Kathleen E. Brummel‐Ziedins, Joanna Natorska, Andrzej Szczeklik, Wiesława Tracz, Ewa Wypasek, Jacek Musiał and Ewa Stępień and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Anetta Undas

266 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fibrin Clot Structure and Function

2011 405 citations Anetta Undas, Robert A.S. Ariëns profile →
Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice

2023 80 citations Michał Ząbczyk, Robert A.S. Ariëns et al. Cardiovascular Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anetta Undas Poland	40	2.2k	1.9k	1.4k	1.4k	1.4k	282	6.3k
Anetta Undas Poland	37	1.9k 0.9×	1.2k 0.6×	1.1k 0.8×	1.2k 0.9×	1.4k 1.0×	248	4.9k
Domenico Prisco Italy	52	3.1k 1.4×	1.6k 0.8×	1.7k 1.2×	2.3k 1.6×	2.0k 1.4×	376	9.5k
Henri M.H. Spronk Netherlands	52	2.5k 1.1×	983 0.5×	1.1k 0.8×	1.6k 1.1×	3.0k 2.1×	226	8.9k
Giovanni Di Minno Italy	54	2.5k 1.2×	1.0k 0.5×	1.4k 1.0×	1.5k 1.1×	4.1k 2.9×	323	9.4k
Anne‐Mette Hvas Denmark	44	2.0k 0.9×	636 0.3×	1.2k 0.8×	1.2k 0.8×	1.7k 1.2×	306	6.3k
Betti Giusti Italy	45	2.7k 1.2×	951 0.5×	1.7k 1.2×	809 0.6×	707 0.5×	211	6.8k
Peter Quehenberger Austria	47	2.1k 1.0×	692 0.4×	1.1k 0.8×	2.8k 1.9×	3.0k 2.1×	204	7.8k
Siegmund Braun Germany	40	3.5k 1.6×	671 0.3×	2.1k 1.4×	956 0.7×	950 0.7×	128	6.8k
Renate Koppensteiner Austria	39	2.1k 1.0×	1.8k 0.9×	2.3k 1.6×	1.1k 0.7×	467 0.3×	245	5.6k
Matteo Nicola Dario Di Minno Italy	49	1.7k 0.8×	568 0.3×	1.4k 1.0×	1.4k 0.9×	1.9k 1.4×	274	8.2k

Countries citing papers authored by Anetta Undas

Since Specialization

Citations

This map shows the geographic impact of Anetta Undas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anetta Undas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anetta Undas more than expected).

Fields of papers citing papers by Anetta Undas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anetta Undas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anetta Undas. The network helps show where Anetta Undas may publish in the future.

Co-authorship network of co-authors of Anetta Undas

This figure shows the co-authorship network connecting the top 25 collaborators of Anetta Undas. A scholar is included among the top collaborators of Anetta Undas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anetta Undas. Anetta Undas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ząbczyk, Michał, et al.. (2025). Statin treatment reduces protein carbonylation in patients with COPD: A randomized controlled study. European Journal of Clinical Investigation. 55(4). e70009–e70009. 1 indexed citations

Ząbczyk, Michał, et al.. (2025). Elevated Factor XI is Associated with First and Recurrent Left Atrial Appendage Thrombus of Unknown Origin. Thrombosis and Haemostasis.

Bazan‐Socha, Stanisława, Lucyna Mastalerz, Lech Zaręba, et al.. (2025). Factor VIIa–Antithrombin Complexes are Increased in Asthma: Relation to the Exacerbation-Prone Asthma Phenotype. Thrombosis and Haemostasis. 126(1). 37–48.

Konieczyńska, Małgorzata, Joanna Natorska, Michał Ząbczyk, & Anetta Undas. (2024). Lp(a) and thromboembolism: current state of knowledge and unsolved issues. Archives of Medical Science. 20(6). 1770–1783. 1 indexed citations

Ząbczyk, Michał, et al.. (2024). Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin. European Journal of Clinical Investigation. 54(8). e14196–e14196. 4 indexed citations

Malinowski, Krzysztof Piotr, et al.. (2023). Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease. European Journal of Clinical Investigation. 53(9). e14007–e14007. 6 indexed citations

Natorska, Joanna, Javier Corral, María Eugenia de la Morena‐Barrio, et al.. (2023). Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype. Thrombosis and Haemostasis. 123(9). 880–891. 8 indexed citations

Ząbczyk, Michał, Robert A.S. Ariëns, & Anetta Undas. (2023). Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovascular Research. 119(1). 94–111. 80 indexed citations breakdown →

Kopiński, Piotr, et al.. (2023). Neutrophil extracellular traps (NETs) in aortic stenosis: Comparison of methods for assessment of NETs formation. Postępy Higieny i Medycyny Doświadczalnej. 77(1). 163–169. 2 indexed citations

10.

Plicner, Dariusz, Ewa Wypasek, Joanna Natorska, et al.. (2022). Impaired fibrin clot lysis is associated with increased mortality in patients after coronary artery bypass grafting: A long‐term follow‐up study. European Journal of Clinical Investigation. 52(7). e13775–e13775. 1 indexed citations

11.

Ząbczyk, Michał, Joanna Natorska, Agnieszka Janion−Sadowska, et al.. (2021). Isoprostane‐8 and GDF‐15 as novel markers of post‐PE syndrome: Relation with prothrombotic factors. European Journal of Clinical Investigation. 52(1). e13660–e13660. 3 indexed citations

12.

Ząbczyk, Michał, Joanna Natorska, & Anetta Undas. (2021). Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes. Journal of Clinical Medicine. 10(13). 2999–2999. 28 indexed citations

13.

Mazur, Piotr, et al.. (2021). Towards Personalized Therapy of Aortic Stenosis. Journal of Personalized Medicine. 11(12). 1292–1292. 4 indexed citations

14.

Ząbczyk, Michał, et al.. (2019). The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants. Clinical Chemistry and Laboratory Medicine (CCLM). 57(9). 1374–1381. 42 indexed citations

15.

Zaręba, Lech, et al.. (2019). Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations. Disease Markers. 2019. 1–7. 17 indexed citations

16.

Matusik, Paweł T., Barbara Małecka, Jacek Lelakowski, & Anetta Undas. (2019). Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation. Clinical Research in Cardiology. 109(4). 426–434. 20 indexed citations

17.

Wojtukiewicz, Marek Z., Ewa Sierko, Witold Tomkowski, et al.. (2016). Guidelines for the prevention and treatment of venous thromboembolism in patients with cancers treated conservatively. Via Medica Journals. 6 indexed citations

18.

Stępień, Ewa, et al.. (2010). Optymalizacja leczenia antagonistami witaminy K : rola polimorfizmów genowych. Jagiellonian University Repository (Jagiellonian University). 1 indexed citations

19.

Mamcarz, Artur, Piotr Podolec, Grzegorz Kopeć, et al.. (2010). Polish forum for prevention guidelines on metabolic syndrome.. PubMed. 68(1). 121–4. 2 indexed citations

20.

Undas, Anetta, Piotr Podolec, Grzegorz Kopeć, et al.. (2007). Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.. PubMed. 65(11). 1396–8. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact